Created at Source Raw Value Validated value
Oct. 26, 2020, 7:26 a.m. eu

1. Adult patients, 18 years and above 2. Confirmed SARS-2-CoV-2 infection by PCR 3. Admitted to the hospital ward or the ICU 4. Subjects provides written informed consent prior to initiation of the study 5. No anticipated transfer within 72 hours to a non-study hospital 6. If heterosexually active, men and women of child bearing potential must practice a highly effective method of birth control, including combined (estrogen and progestogen containing) hormonal prescription oral, intravaginal, transdermal contraceptives, or progestogen containing hormonal prescription oral, injectable, implantable contraceptives or intrauterine device (IUD), or intrauterine hormone-releasing systems (IUS), or male partner sterilization. The above methods of contraception must be agreed to be used up to the last visit, Follow up 3 months.

1. Adult patients, 18 years and above 2. Confirmed SARS-2-CoV-2 infection by PCR 3. Admitted to the hospital ward or the ICU 4. Subjects provides written informed consent prior to initiation of the study 5. No anticipated transfer within 72 hours to a non-study hospital 6. If heterosexually active, men and women of child bearing potential must practice a highly effective method of birth control, including combined (estrogen and progestogen containing) hormonal prescription oral, intravaginal, transdermal contraceptives, or progestogen containing hormonal prescription oral, injectable, implantable contraceptives or intrauterine device (IUD), or intrauterine hormone-releasing systems (IUS), or male partner sterilization. The above methods of contraception must be agreed to be used up to the last visit, Follow up 3 months.